Pacira | PCRX - Current Assets

Stock Price
24.51
Daily Change
-0.85 -3.35%
Monthly
4.34%
Yearly
-4.70%
Q2 Forecast
23.99

Pacira reported $547.97M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Assertio Holdings USD 263.57M 53.36M Sep/2025
Astellas Pharma JPY 1.44T 72.43B Dec/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Cara Therapeutics USD 38.44M 4.69M Sep/2025
Coherus Biosciences USD 206.71M 254.25M Dec/2025
Heron Therapeutics USD 238.07M 8.67M Dec/2025
Ironwood Pharmaceuticals USD 273.84M 82.09M Sep/2025
J&J USD 59.17B 3.55B Mar/2026
Ligand Pharmaceuticals USD 832.27M 78.35M Dec/2025
Nektar Therapeutics USD 266.27M 15.09M Dec/2025
Novo Nordisk DKK 172.45B 9.43B Dec/2025
Omeros USD 69.65M 26.53M Jun/2025
Pacira USD 547.97M 14.78M Dec/2025
Perrigo USD 2.8B 81.8M Dec/2025
Pfizer USD 46.92B 3.22B Sep/2025
Supernus Pharmaceuticals USD 644.18M 50.29M Dec/2025
Teva Pharmaceutical Industries USD 13.95B 1.21B Dec/2025
Xeris Pharmaceuticals USD 240.31M 16.3M Dec/2025
Xoma USD 110.71M 5.78M Sep/2025
Zoetis USD 6.77B 185M Dec/2025